Search INBS
Intelligent Bio Solutions Inc.
NasdaqCM · CIK 1725430
Last close1.66
Daily change+0.00 (0.00%)
10 Years gain-99.99%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
INBS · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0630
Fundamental
52.3Momentum
100.0Acceleration
60.0Confidence
78.0Annual Revenue7
Quarterly Revenue22
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality8.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet13.0 / 15
Shareholder Economics3.6 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 53.5872 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 11.5573 percentage points.
Heavy share dilution · HIGHDiluted share count increased 176.251%.
ROIC declining · MEDIUMROIC declined by 14.932 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM33.26%OK
Revenue CAGR 3Y49.68%OK
Gross Margin47.25%OK
Operating Margin-299.28%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-419.99%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO0.63xOK
Diluted Share Growth 1Y176.25%OK
SBC / Revenue2.81%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jun 30, 2026 | $4.22M | $2.05M | -$12.61M | -$11.93M | -$12.05M | 48.63% | -299.11% | -285.94% | -570.02% | 1.47M |
| 2026 FY Jun 30, 2025 | $3.05M | $1.25M | -$10.68M | -$9.68M | -$9.91M | 40.85% | -349.85% | -324.62% | -421.67% | 527,364 |
| 2025 FY Jun 30, 2024 | $3.11M | $1.43M | -$10.28M | -$9.57M | -$9.79M | 45.81% | -330.46% | -314.71% | -378.99% | 1.59M |
| 2024 FY Jun 30, 2023 | $1.26M | $326,668.00 | -$12.60M | -$7.38M | n/a | 25.99% | -1,002.11% | n/a | -3,069.35% | 83,717 |
| 2023 FY Jun 30, 2022 | n/a | $437,146.00 | -$8.34M | -$3.36M | n/a | n/a | n/a | n/a | n/a | 733,263 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $3.91M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-039136, 0001493152-25-021751 |
| Revenue Growth TTM | 33.26% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-039136, 0001493152-25-021751 |
| Revenue CAGR 3Y | 49.68% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-039136 |
| Revenue CAGR 5Y | 16.31% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-039136 |
| Gross Profit CAGR 3Y | 84.45% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-039136 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-039136, 0001493152-25-021751 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 47.25% | Gross Profit / Revenue | OK | 0001493152-26-039136, 0001493152-25-021751 |
| Operating Margin | -299.28% | Operating Income / Revenue | OK | 0001493152-26-039136, 0001493152-25-021751 |
| ROIC | -419.99% | NOPAT / Average Invested Capital | OK | 0001493152-26-039136, 0001493152-25-021751 |
| Net Debt / CFO | 0.63x | Net Debt / CFO | OK | 0001493152-26-022617, 0001493152-26-039136 |
| Current Ratio | 2.11x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 2.81% | SBC / Revenue | OK | 0001493152-26-039136, 0001493152-25-021751 |
| Revenue per Diluted Share | $2.45 | Revenue / Diluted Shares | OK | 0001493152-26-039136, 0001493152-25-021751 |